Title : Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure.

Pub. Date : 2004 May 15

PMID : 15135713






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This randomized, placebo-controlled trial showed that levosimendan administration causes a significant reduction of circulating proinflammatory cytokine interleukin-6 and soluble apoptosis mediators, such as soluble Fas and Fas ligand in patients with decompensated heart failure. Simendan interleukin 6 Homo sapiens